Interviews - Page 2 of 26 - Express Pharma

What truly differentiates Transchem is our technical-first approach

Targeted incentives for innovation-driven research would further strengthen India’s biotech ecosystem

In 2026, India serves as the reliable ‘technical engine’ for global research

Our approach is to combine localised production with global quality standards

India has the infrastructure to lead the global gene therapy market

BMS is committed to pioneering AI-driven innovation in pharma commercialisation

Automation, digitalisation, and integrated workflows are redefining India’s life sciences landscape

Quick-commerce players are rapidly gaining share in acute, event-based medicines

Rx-to-OTC is not a channel shift—it’s a complete business model shift

Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero